Randomized trials testing various anticoagulant strategies are coming, including the large US National Institutes of Health-sponsored ACTIV-4 trial, but given the recent spikes and surges in COVID-19 case numbers, many frontline doctors are still grappling with the thromboembolic risks associated with the infectious disease. That was the consensus among a group of experts gathered to kick off the TCT Connect 2020. In a session dedicated to interventional cardiology in the COVID-19 era, Sanjum Sethi, MD (NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY), highlighted the struggle many physicians face when dealing with these critically ill patients at high risk for venous thromboembolism (VTE). Continue reading →

Medtronic Also BeginsFeasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN,Oct. 14, 2020 Medtronic plc announced it will begin a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). Continue reading →

Newswise NEW YORK October 14, 2020 New data from PROSPECT ABSORB, a pilot randomized trial of percutaneous coronary intervention (PCI) of non-flow-limiting vulnerable plaques in native coronary arteries, found that PCI was safe, substantially enlarged follow-up lumen areas, and was associated with favorable long-term clinical outcomes. Findings were reported today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation (CRF) Continue reading →

Newswise Kansas City, Missouri & Cleveland, Ohio--The Cardiometabolic Center Alliance (CMCA), founded by Saint Lukes Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member. As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance. The goal of the Cardiometabolic Center Alliance is building on our existing success in Kansas City by working collaboratively with our member organizations to replicate and refine our novel clinical care delivery model, with the overarching objective of lessening the adverse impact of diabetes and its most common and morbid complications cardiovascular and kidney disease - on patients lives, said Dr. Continue reading →

(UPDATED)Patients with STEMI and COVID-19 are uniquely high risk, North American registry data show. And for patients whose door-to-balloon (D2B) times are similar to those without the viral disease, researchers say, primary PCI is preferable and feasible. COVID-19s implications for STEMI are well knownmany people experiencing heart attack symptoms have put off care during the pandemic, for example, and among patients hospitalized with the SARS-CoV-2 virus, 15% have elevated troponins, investigator Timothy Henry, MD (The Christ Hospital, Cincinnati, OH), said in a late-breaking session today during TCT Connect 2020. Continue reading →